Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?

BACKGROUND: RANTES (regulated on activation, normal T cell expressed and secreted) expression is increased in inflammatory bowel disease (IBD). RANTES is produced at higher levels in granulomatous conditions, so increased RANTES expression can be expected in Crohn's disease compared with ulcerative colitis. AIM: To compare RANTES expression between intestinal biopsy specimens of patients with Crohn's disease and those with ulcerative colitis. MATERIALS AND METHODS: A prospective study of patients presenting with lower gastrointestinal symptoms at the Bahrain Specialist Hospital from July 2004 to April 2005 was carried out. Endoscopic colonic biopsy specimens were taken from every patient and subjected to (a) routine haematoxylin and eosin staining examination by light microscopy, (b) immunohistochemistry for examination of RANTES protein expression by light microscopy and (c) in situ hybridisation for examination of RANTES mRNA expression by light microscopy. RANTES expression was assessed and quantified. RESULTS: 58 patients were enrolled to the study. Of them, 40 had IBD (21 had Crohn's disease and 19 had ulcerative colitis), 15 were controls with normal colonic biopsy results or non‐inflammatory lesions and 3 had colonic inflammatory lesions other than IBD. RANTES expression in lymphocytes or histiocytes was significantly higher (p = 0.04) in new patients with ulcerative colitis than in those with Crohn's disease analysed by immunohistochemistry (IHC). CONCLUSION: RANTES expression in lymphocytes or histiocytes is significantly higher in patients with ulcerative colitis than in those with Crohn's disease. Hence, RANTES IHC can be an effective method for distinguishing between biopsy specimens of patients with ulcerative colitis from those of patients with Crohn's disease, where routine histological features are indeterminate. RANTES IHC may prove to be a useful technique for identifying early or equivocal granulomas

Photocatalysis and catalytic wet air oxidation:degradation and toxicity of bisphenol A containing wastewaters

Abstract Bisphenol A (BPA) is a commonly used chemical in consumer products. It is an endocrine disrupter that has potentially significant negative effects on human health. The use and chemical stability of BPA have resulted in the appearance of the chemical in wastewaters. Since the current wastewater treatment technologies are not effective enough to remove BPA, new methods to degrade BPA are required. In this paper, we report the efforts made towards developing a bi-functional catalyst for consecutive catalytic wet air oxidation-photocatalytic water treatment. It was found that 2.5% Pt/Ti0.8Ce0.2O2 is a potential bi-functional catalyst for the consecutive treatment. Concentration and toxicity of BPA were successfully reduced by catalytic wet air oxidation. Although BPA was further reduced by photocatalysis, it was not reflected in further decrease of cell toxicity. Thus wet-air oxidation combined with photocatalysis is a promising approach for the reduction of BPA